These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17072337)

  • 1. Regulation of survivin expression by IGF-1/mTOR signaling.
    Vaira V; Lee CW; Goel HL; Bosari S; Languino LR; Altieri DC
    Oncogene; 2007 Apr; 26(19):2678-84. PubMed ID: 17072337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor-I receptor signaling pathway induces resistance to the apoptotic activities of SCH66336 (lonafarnib) through Akt/mammalian target of rapamycin-mediated increases in survivin expression.
    Oh SH; Jin Q; Kim ES; Khuri FR; Lee HY
    Clin Cancer Res; 2008 Mar; 14(5):1581-9. PubMed ID: 18316583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation.
    Roca H; Varsos Z; Pienta KJ
    J Biol Chem; 2008 Sep; 283(36):25057-73. PubMed ID: 18611860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of a survivin/TGF-β/mTORC1 axis in IGF-I-mediated growth of prostate epithelial cells.
    Song K; Shankar E; Yang J; Bane KL; Wahdan-Alaswad R; Danielpour D
    PLoS One; 2013; 8(5):e61896. PubMed ID: 23658701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter.
    Chun JY; Hu Y; Pinder E; Wu J; Li F; Gao AC
    Mol Cancer Ther; 2007 Sep; 6(9):2572-80. PubMed ID: 17876054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of survivin by PI3K/Akt/p70S6K1 pathway.
    Zhao P; Meng Q; Liu LZ; You YP; Liu N; Jiang BH
    Biochem Biophys Res Commun; 2010 Apr; 395(2):219-24. PubMed ID: 20361940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib.
    Morgillo F; Woo JK; Kim ES; Hong WK; Lee HY
    Cancer Res; 2006 Oct; 66(20):10100-11. PubMed ID: 17047074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling.
    Zhang D; Brodt P
    Oncogene; 2003 Feb; 22(7):974-82. PubMed ID: 12592384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biological implications of the inhibition of survivin by RNA interference in human androgen-independent prostate carcinoma with highly metastatic potential].
    Zhu X; Ning JY; You JF; Wang JL; Cui XL; Fang WG; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):549-54. PubMed ID: 17134550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of survivin gene by small interfering RNAs produces supra-additive growth suppression in combination with 17-allylamino-17-demethoxygeldanamycin in human prostate cancer cells.
    Paduano F; Villa R; Pennati M; Folini M; Binda M; Daidone MG; Zaffaroni N
    Mol Cancer Ther; 2006 Jan; 5(1):179-86. PubMed ID: 16432177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
    deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
    Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF-IR-dependent expression of Survivin is required for T-antigen-mediated protection from apoptosis and proliferation of neural progenitors.
    Gualco E; Urbanska K; Perez-Liz G; Sweet T; Peruzzi F; Reiss K; Del Valle L
    Cell Death Differ; 2010 Mar; 17(3):439-51. PubMed ID: 19834489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
    Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
    Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells.
    Roca H; Varsos ZS; Pienta KJ
    Neoplasia; 2009 Dec; 11(12):1309-17. PubMed ID: 20019839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
    Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI
    Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Down-regulation of mTOR activity and survivin expression during tamoxifen-induced apoptosis in hepatoblastoma cells].
    Guo RH; Wang TS; Chen XF; Huang ZH; Shu YQ
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):903-6. PubMed ID: 21223797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin mediates resistance to antiandrogen therapy in prostate cancer.
    Zhang M; Latham DE; Delaney MA; Chakravarti A
    Oncogene; 2005 Apr; 24(15):2474-82. PubMed ID: 15735703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells.
    Pennati M; Binda M; Colella G; Zoppe' M; Folini M; Vignati S; Valentini A; Citti L; De Cesare M; Pratesi G; Giacca M; Daidone MG; Zaffaroni N
    Oncogene; 2004 Jan; 23(2):386-94. PubMed ID: 14724567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
    Jernberg-Wiklund H; Nilsson K
    Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
    Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.